LB PHARMACEUTICALS INC — Director's Dealing 2025

Sep 17, 2025

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: LB PHARMACEUTICALS INC (LBRX)
CIK: 0001691082
Period of Report: 2025-09-12

Reporting Person: Deep Track Special Opportunities Fund, LP (N/A)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	666666	Direct

Footnotes

F1: Represents securities held by Deep Track Special Opportunities Fund, LP. Deep Track Capital, LP is the investment manager of Deep Track Special Opportunities Fund, LP. Mr. David Kroin is the managing member of Deep Track Capital GP, LLC, the general partner of Deep Track Capital, LP., and by virtue of such status may be deemed to be the beneficial owner of the shares owned by Deep Track Special Opportunities Fund, LP. Affiliates of the Reporting Person, including Deep Track Biotechnology Master Fund, Ltd, Deep Track Capital, LP and Mr. Kroin, have separately filed Section 16 reports with respect to the shares of Issuer common stock they may be deemed to beneficially own.